Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178253-15-000114
Filing Date
2015-10-05
Accepted
2015-10-05 18:23:48
Documents
1
Period of Report
2015-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_144408381810379.html 4  
1 FORM 4 wf-form4_144408381810379.xml 4 3785
  Complete submission text file 0001178253-15-000114.txt   5054
Mailing Address 3501-C TRICENTER BLVD DURHAM NC 27713
Business Address 3501-C TRICENTER BLVD DURHAM NC 27713 919-544-8600
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
GILMAN STEVEN C (Reporting) CIK: 0001379970 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36365 | Film No.: 151144554